Updated on 2025/02/21

写真a

 
HIROYASU SHO
 
Organization
Graduate School of Medicine Department of Clinical Medical Science Lecturer
School of Medicine Department of Medical Science
Title
Lecturer
Affiliation
Institute of Medicine
Affiliation campus
Abeno Campus

Position

  • Graduate School of Medicine Department of Clinical Medical Science 

    Lecturer  2023.04 - Now

  • School of Medicine Department of Medical Science 

    Lecturer  2023.04 - Now

Degree

  • 博士(医学) ( Osaka City University )

  • 学士(医学) ( Osaka City University )

Research Areas

  • Life Science / Dermatology

Research Interests

  • Vitiligo vulgaris

  • 自己免疫性水疱症

  • ヘミデスモソーム

  • プロテアーゼ

Professional Memberships

  • Japanese Society of Vitiligo

  • 日本研究皮膚科学会

  • 日本皮膚科学会

Awards

  • UJA論文賞特別賞

    2022.05   海外日本人研究者ネットワーク  

  • Hacking-Dermatology 最優秀賞、Sparking賞

    2021.11   レオファーマ株式会社  

  • Trainee Travel Award

    2019.06   ICORD, University of British Columbia  

  • Top Post-Doctoral Fellow Abstract at UBC Pathology Day

    2019.05   Pathology and Laboratory of Medicine, University of British Columbia  

  • Best Scientific Paper for the Division of Plastic Surgery Research Day

    2019.04   Division of Plastic Surgery, University of British Columbia  

Job Career (off-campus)

  • Osaka Metropolitan University   Department of Dermatology   Assistant professor

    2023.04 - Now

  • 大阪公立大学大学院医学研究科皮膚病態学   後記臨床研究医

    2022.04 - 2023.03

  • 大阪市立大学大学院医学研究科   皮膚病態学   後記臨床研究医

    2021.04 - 2022.03

  • 大阪市立大学大学院医学研究科   皮膚病態学   前記臨床研究医

    2020.11 - 2021.03

  • 大阪市立大学大学院医学研究科   皮膚病態学   医員

    2020.10

  • University of British Columbia   Department of Pathology and Laboratory Medicine   Postdoc fellow

    2017.10 - 2020.09

▼display all

Papers

  • Clinical characteristics and outcomes of autoimmune blistering diseases in Japan. Reviewed

    Maria Rosa Noliza Encarnacion, Ryota Kawai, Hiroto Kuwabiraki, Nanaka Ban, Hisako Yoshida, Ayumi Shintani, Daisuke Tsuruta, Sho Hiroyasu

    The Journal of dermatology   52 ( 2 )   299 - 308   2024.10( ISSN:03852407

     More details

    Authorship:Last author, Corresponding author   Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Autoimmune blistering diseases (AIBDs), including pemphigoid and pemphigus, are intractable dermatological disorders clinically characterized by blistering and erosion affecting mucosal membranes and the skin. Due to their rarity and the limited coverage for less severe cases under Japanese medical subsidies, comprehensive epidemiological analyses encompassing less severe cases have not been conducted in Japan. In this study, we analyzed the epidemiology of AIBDs in Japan, utilizing data from a Japanese nationwide database. We identified 9796 cases of bullous pemphigoid (BP), 62 cases of epidermolysis bullosa acquisita (EBA), 871 cases of pemphigus vulgaris (PV), and 578 cases of pemphigus foliaceous (PF). BP patients exhibited an older age distribution compared to EBA, PV, and PF, with median ages of 81, 72, 65, and 70 years, respectively. Higher rates of comorbidities such as Alzheimer's disease, spondylopathies, and extrapyramidal and movement disorders were observed only in BP cases, while other neurodegenerative disorders such as polyneuropathies, unspecified dementia, and schizophrenia were frequent in both BP and EBA. Dipeptidyl peptidase-4 inhibitors were more commonly prescribed before the onset of BP and EBA compared to PV and PF. Treatment patterns indicated that PV patients were more frequently administered higher doses of oral corticosteroids compared to other AIBDs. Additionally, aggressive therapies, including steroid pulse, intravenous immunoglobulin, and plasmapheresis therapies, were more frequently applied in PV cases. In-hospital mortality rates were higher in BP and EBA at 8.0% and 11.3%, respectively, compared to PV and PF at 2.8% and 5.9%, respectively. Kaplan-Meier analysis indicated that BP and EBA reached a 5-year in-hospital mortality rate of approximately 0.21 and 0.34, while PV and PF rates were approximately 0.07 and 0.11, respectively. The Cox hazard model revealed that higher age is the risk factor for in-hospital mortality in all diseases. Kaplan-Meier analysis indicated a cumulative steroid cessation probability of 0.25 at 3 years for BP, and at 6 and 5 years for PV and PF, respectively. The Cox hazard model revealed that higher age and lower maximum corticosteroid dose contribute to the steroid cessation probability in BP, PV, and PF. This study provides insights into the epidemiology, treatment patterns, comorbidities, and outcomes of AIBDs in Japan.

    DOI: 10.1111/1346-8138.17518

    PubMed

  • Granzyme serine proteases in inflammation and rheumatic diseases Reviewed International coauthorship

    Alexandre Aubert, Karen Jung, Sho Hiroyasu, Julian Pardo, David J. Granville

    Nature Reviews Rheumatology   20 ( 6 )   361 - 376   2024.06( ISSN:17594790

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    DOI: 10.1038/s41584-024-01109-5

    PubMed

  • Differentiating generalized pustular psoriasis from acute generalized exanthematous pustulosis. Reviewed International coauthorship

    Mika Yamanaka-Takaichi, Miki Watanabe, Nneka I Comfere, Olayemi Sokumbi, Christeebella O Akpala, Austin Todd, Emily L Branch, Aaron R Mangold, Sho Hiroyasu, Daisuke Tsuruta, Afsaneh Alavi

    Journal of the American Academy of Dermatology   90 ( 6 )   1289 - 1291   2024.03( ISSN:01909622

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    DOI: 10.1016/j.jaad.2024.01.080

    PubMed

  • The pathological function of neutrophils in pemphigoid diseases Reviewed

    Matsumoto D.

    Dermatologica Sinica   42 ( 2 )   80 - 88   2024( ISSN:10278117

     More details

    Authorship:Last author, Corresponding author   International / domestic magazine:International journal  

    DOI: 10.4103/ds.DS-D-24-00027

  • Granzyme K mediates IL-23-dependent inflammation and keratinocyte proliferation in psoriasis. Reviewed International coauthorship

    Katlyn C Richardson, Alexandre Aubert, Christopher T Turner, Layla Nabai, Sho Hiroyasu, Megan A Pawluk, Rachel A Cederberg, Hongyan Zhao, Karen Jung, Angela Burleigh, Richard I Crawford, David J Granville

    Frontiers in immunology   15   1398120 - 1398120   2024

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Psoriasis is an inflammatory disease with systemic manifestations that most commonly presents as itchy, erythematous, scaly plaques on extensor surfaces. Activation of the IL-23/IL-17 pro-inflammatory signaling pathway is a hallmark of psoriasis and its inhibition is key to clinical management. Granzyme K (GzmK) is an immune cell-secreted serine protease elevated in inflammatory and proliferative skin conditions. In the present study, human psoriasis lesions exhibited elevated GzmK levels compared to non-lesional psoriasis and healthy control skin. In an established murine model of imiquimod (IMQ)-induced psoriasis, genetic loss of GzmK significantly reduced disease severity, as determined by delayed plaque formation, decreased erythema and desquamation, reduced epidermal thickness, and inflammatory infiltrate. Molecular characterization in vitro revealed that GzmK contributed to macrophage secretion of IL-23 as well as PAR-1-dependent keratinocyte proliferation. These findings demonstrate that GzmK enhances IL-23-driven inflammation as well as keratinocyte proliferation to exacerbate psoriasis severity.

    DOI: 10.3389/fimmu.2024.1398120

    PubMed

  • Malignant syphilis in a young immunocompetent patient presenting as ulceronecrotic lesions on the lower extremities.

    Jay-V J Barit, Sho Hiroyasu, Koichi Yamada, Daisuke Tsuruta

    International journal of dermatology   62 ( 8 )   1070 - 1072   2023.03( ISSN:00119059

     More details

    Authorship:Corresponding author   International / domestic magazine:International journal  

    DOI: 10.1111/ijd.16640

    PubMed

  • Granzyme B Contributes to Choroidal Neovascularization and Age-Related Macular Degeneration Through Proteolysis of Thrombospondin-1. Reviewed International coauthorship

    Gideon Obasanmi, Matthew R Zeglinski, Ella Hardie, Anna-Catharina Wilhelm, Christopher T Turner, Sho Hiroyasu, Wendy A Boivin, Yuan Tian, Hongyan Zhao, Eleanor To, Jing Z Cui, Jeanne Xi, Hyung-Suk Yoo, Manjosh Uppal, David J Granville, Joanne A Matsubara

    Laboratory investigation; a journal of technical methods and pathology   103 ( 6 )   100123 - 100123   2023.02

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Age-related macular degeneration (AMD) is a leading cause of irreversible central vision loss in the elderly. The pathology of neovascular age-related macular degeneration (nAMD), also known as wet AMD, is associated with an abnormal blood vessel growth in the eye and involves an imbalance of proangiogenic and antiangiogenic factors. Thrombospondin (TSP)-1 and TSP-2 are endogenous matricellular proteins that inhibit angiogenesis. TSP-1 is significantly diminished in eyes with AMD, although the mechanisms involved in its reduction are unknown. Granzyme B (GzmB) is a serine protease with an increased extracellular activity in the outer retina and choroid of the human eyes with nAMD-related choroidal neovascularization (CNV). This study investigated whether TSP-1 and TSP-2 are GzmB substrates using in silico and cell-free cleavage assays and explored the relationship between GzmB and TSP-1 in the human eyes with nAMD-related CNV and the effect of GzmB on TSP-1 in retinal pigment epithelial culture and an explant choroid sprouting assay (CSA). In this study, TSP-1 and TSP-2 were identified as GzmB substrates. Cell-free cleavage assays substantiated the GzmB proteolysis of TSP-1 and TSP-2 by showing dose-dependent and time-dependent cleavage products. The proteolysis of TSP-1 and TSP-2 were hindered by the inhibition of GzmB. In the retinal pigment epithelium and choroid of human eyes with CNV, we observed a significant inverse correlation between TSP-1 and GzmB, as indicated by lower TSP-1 levels and higher GzmB immunoreactivity. In the CSA, the vascular sprouting area increased significantly with GzmB treatment and reduced significantly with TSP-1 treatment. Western blot showed significantly reduced expression of TSP-1 in GzmB-treated retinal pigment epithelial cell culture and CSA supernatant compared with that in controls. Together, our findings suggest that the proteolysis of antiangiogenic factors such as TSP-1 by extracellular GzmB might represent a mechanism through which GzmB may contribute to nAMD-related CNV. Future studies are needed to investigate whether pharmacologic inhibition of extracellular GzmB can mitigate nAMD-related CNV by preserving intact TSP-1.

    DOI: 10.1016/j.labinv.2023.100123

    PubMed

  • Hereditary angioedema with normal C1 inhibitor with steroid responsiveness in a patient with psychiatric comorbidities. Reviewed

    Jay-V James Barit, Sho Hiroyasu, Yurika Terashima, Yuka Ayano, Daisuke Tsuruta

    The Journal of dermatology   50 ( 6 )   e187 - e188   2023.01( ISSN:03852407

     More details

    Authorship:Last author, Corresponding author   International / domestic magazine:International journal  

    DOI: 10.1111/1346-8138.16713

    PubMed

  • Pruritogens in pemphigoid diseases: Possible therapeutic targets for a burdensome symptom. Reviewed

    Sho Hiroyasu, Jay-V James G Barit, Aoi Hiroyasu, Daisuke Tsuruta

    The Journal of dermatology   50 ( 2 )   150 - 161   2022.12( ISSN:03852407

     More details

    Authorship:Lead author, Corresponding author   Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Pruritus is a hallmark feature in pemphigoid diseases, where it can be severe and greatly impact the quality of life of affected patients. Despite being a key symptom, the exact pathophysiological mechanisms involved in pruritus in pemphigoid are yet to be fully elucidated and effective therapies addressing them are limited. This review summarizes the present understanding of pruritus specific to pemphigoid diseases, especially the pruritogens that induce it, and the therapeutic options that have been explored so far. The majority of the available evidence is on bullous pemphigoid and epidermolysis bullosa acquisita. Histamine derived from basophils correlates with pruritus severity, with omalizumab demonstrating promising efficacy in pruritus for bullous pemphigoid. IL-4/-13 contribute to itch in bullous pemphigoid with dupilumab being evaluated in clinical trials. Other pruritogens of interest include substance P, tryptase, and thymic stromal lymphopoetin, with therapies targeting them requiring further investigation. Scratching behaviors contribute directly to blister formation through various mechanisms, such as pathological autoantibody recruitment, T helper cell type 1 polarization, and exposure of intracellular autoantigens. Treatments addressing these pathways may contribute to decreasing disease severity. Additional studies are needed to fully characterize how pruritus is regulated in pemphigoid diseases, to help pave the way to develop novel and effective therapeutics that will not only address pruritic symptoms but also decrease disease severity.

    DOI: 10.1111/1346-8138.16652

    PubMed

  • Implications of Sm22α-Cre expression in keratinocytes and unanticipated inflammatory skin lesion in a model of atherosclerosis.

    Mei Hu, Sho Hiroyasu, David J Granville, Zamaneh Kassiri

    American journal of physiology. Heart and circulatory physiology   323 ( 3 )   H528-H534 - H534   2022.09( ISSN:03636135

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Genetically modified mice are widely used to recapitulate human diseases. Atherosclerosis can be induced in mice with low-density lipoprotein receptor (Ldlr)-deficiency and a high-fat diet (HFD). Disintegrin and metalloproteinase-17 (ADAM17) in the smooth muscle cell (SMC) contribute to vascular pathologies, and hence its role in atherosclerosis was investigated. Adam17 deletion in SMCs by Sm22α-Cre driver (Ldlr-/-/Adam17Sm22Cre) and HFD resulted in severe skin lesions in >70% of mice, associated with skin inflammation, which was not observed in Ldlr-/--HFD, nor in mice with SMC deficiency of Adam17 by a different Cre driver (Ldlr-/-/Adam17Myh11Cre). We found that Sm22α is highly expressed in keratinocytes (compared with SMCs), which could underlie the observed skin lesion in Ldlr-/-/Adam17Sm22Cre-HFD. Although expression of Sm22α in non-SMCs has been reported, this is the first study demonstrating a severe side effect resulting from the off-target expression of Sm22α-Cre, resulting in ADAM17 loss in keratinocytes that led to a moribund state.NEW & NOTEWORTHY Although Sm22α-Cre is commonly used to target gene deletion in smooth muscle cells, Sm22α-derived Adam17 deletion resulted in unexpected severe skin lesions following high-fat diet feeding in a model of atherosclerosis. Adam17 deletion by a different SMC driver, Myh11-Cre, did not result in skin lesions in the same atherosclerosis model. Sm22α is highly expressed in keratinocytes, causing ectopic loss of ADAM17 in keratinocytes that caused significant epidermal lesions when combined with a high-fat diet.

    DOI: 10.1152/ajpheart.00325.2022

    PubMed

  • Stabilization of Hemidesmosomal Proteins: A Possible Key Contributor to Wnt/β-Catenin Pathway Action in the Skin

    Sho Hiroyasu, Daisuke Tsuruta

    Journal of Investigative Dermatology   142 ( 6 )   1514 - 1516   2022.06( ISSN:0022202X

     More details

    Authorship:Lead author   Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    DOI: 10.1016/j.jid.2021.11.016

    PubMed

  • Case of pemphigoid nodularis with immunoglobulin (Ig)G deposition accompanied by postinflammatory hypopigmentation without IgG deposition on the same forearm

    Sho Hiroyasu, Aoi Hiroyasu, Mako Mine, Yorihisa Kotobuki, Daisuke Tsuruta

    The Journal of Dermatology   49 ( 3 )   e99-e101   2022.03

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    DOI: 10.1111/1346-8138.16244

    PubMed

  • Pathological functions of granzyme B in inflammatory skin diseases.

    Sho Hiroyasu, Aoi Hiroyasu, David J Granville, Daisuke Tsuruta

    Journal of dermatological science   104 ( 2 )   76 - 82   2021.11

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Dysregulated skin immunity is a hallmark of many skin diseases such as atopic dermatitis, autoimmune blistering diseases, and interface dermatitis. Current treatment options for the inflammatory skin diseases are limited and sometimes ineffective, therefore further understanding of pathomechanisms in the inflammatory skin conditions is necessary to develop new therapeutic alternatives. Recent studies suggest that the serine protease, granzyme B, is a key mediator in multiple inflammatory skin diseases, implying that strategies targeting granzyme B may be an attractive treatment option for such diseases. Specifically, granzyme B exhibits not only an intracellular apoptotic function but also extracellular proteolytic roles in inflammatory skin diseases including infectious diseases, pemphigoid diseases, atopic dermatitis, alopecia areata, and interface dermatitis. In this review, we summarize the current understanding with respect to the functions of granzyme B in the pathomechanism of various inflammatory skin diseases and evaluate the possibility of therapeutics targeting granzyme B.

    DOI: 10.1016/j.jdermsci.2021.10.006

    PubMed

  • Granzyme B mediates impaired healing of pressure injuries in aged skin.

    Christopher T Turner, Juliana Bolsoni, Matthew R Zeglinski, Hongyan Zhao, Tatjana Ponomarev, Katlyn Richardson, Sho Hiroyasu, Erin Schmid, Anthony Papp, David J Granville

    NPJ aging and mechanisms of disease   7 ( 1 )   6 - 6   2021.03

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Pressure injuries (PIs), also known as bedsores or pressure ulcers, are a major cause of death and morbidity in the elderly. The serine protease, Granzyme B (GzmB), contributes to skin aging and impaired wound healing. Aging is a major risk factor for PIs; thus, the role of GzmB in PI pathogenesis was investigated. GzmB levels in human PI tissue and wound fluids were markedly elevated. A causative role for GzmB was assessed in GzmB knockout (GzmB-/-) and wild-type (WT) mice using a murine model of PI. An apolipoprotein E knockout (ApoE-/-) model of aging and vascular dysfunction was also utilized to assess GzmB in a relevant age-related model better resembling tissue perfusion in the elderly. PI severity displayed no difference between young GzmB-/- and WT mice. However, in aged mice, PI severity was reduced in mice lacking GzmB. Mechanistically, GzmB increased vascular wall inflammation and impaired extracellular matrix remodeling. Together, GzmB is an important contributor to age-dependent impaired PI healing.

    DOI: 10.1038/s41514-021-00059-6

    PubMed

  • Granzyme B inhibition reduces disease severity in autoimmune blistering diseases Reviewed

    Sho Hiroyasu, Matthew R. Zeglinski, Hongyan Zhao, Megan A. Pawluk, Christopher T. Turner, Anika Kasprick, Chiharu Tateishi, Wataru Nishie, Angela Burleigh, Peter A. Lennox, Nancy Van Laeken, Nick J. Carr, Frank Petersen, Richard I. Crawford, Hiroshi Shimizu, Daisuke Tsuruta, Ralf J. Ludwig, David J. Granville

    Nature Communications   12 ( 1 )   2021.01( eISSN:2041-1723

     More details

    Authorship:Lead author   Publishing type:Research paper (scientific journal)  

    <title>Abstract</title>Pemphigoid diseases refer to a group of severe autoimmune skin blistering diseases characterized by subepidermal blistering and loss of dermal-epidermal adhesion induced by autoantibody and immune cell infiltrate at the dermal-epidermal junction and upper dermis. Here, we explore the role of the immune cell-secreted serine protease, granzyme B, in pemphigoid disease pathogenesis using three independent murine models. In all models, granzyme B knockout or topical pharmacological inhibition significantly reduces total blistering area compared to controls. In vivo and in vitro studies show that granzyme B contributes to blistering by degrading key anchoring proteins in the dermal-epidermal junction that are necessary for dermal-epidermal adhesion. Further, granzyme B mediates IL-8/macrophage inflammatory protein-2 secretion, lesional neutrophil infiltration, and lesional neutrophil elastase activity. Clinically, granzyme B is elevated and abundant in human pemphigoid disease blister fluids and lesional skin. Collectively, granzyme B is a potential therapeutic target in pemphigoid diseases.

    DOI: 10.1038/s41467-020-20604-3

    Other URL: http://www.nature.com/articles/s41467-020-20604-3

  • Granzyme B Contributes to Barrier Dysfunction in Oxazolone-Induced Skin Inflammation through E-Cadherin and FLG Cleavage. Reviewed

    Christopher T Turner, Matthew R Zeglinski, Katlyn C Richardson, Stephanie Santacruz, Sho Hiroyasu, Christine Wang, Hongyan Zhao, Yue Shen, Roma Sehmi, Hermenio Lima, Gail M Gauvreau, David J Granville

    The Journal of investigative dermatology   141 ( 1 )   36 - 47   2021.01

     More details

    Publishing type:Research paper (scientific journal)   International / domestic magazine:International journal  

    Atopic dermatitis (AD) is the most common inflammatory skin condition. Skin barrier dysfunction is of major importance in AD because it facilitates allergen sensitization and systemic allergic responses. Long regarded as a pro-apoptotic protease, emerging studies indicate granzyme B (GzmB) to have extracellular roles involving the proteolytic cleavage of extracellular matrix, cell adhesion proteins, and basement membrane proteins. Minimally expressed in normal skin, GzmB is elevated in AD and is positively correlated with disease severity and pruritus. We hypothesized that GzmB contributes to AD through extracellular protein cleavage. A causative role for GzmB was assessed in an oxazolone-induced murine model of dermatitis, comparing GzmB-/- mice with wild-type mice, showing significant reductions in inflammation, epidermal thickness, and lesion formation in GzmB-/- mice. Topical administration of a small-molecule GzmB inhibitor reduced disease severity compared with vehicle-treated controls. Mechanistically, GzmB impaired epithelial barrier function through E-cadherin and FLG cleavage. GzmB proteolytic activity contributes to impaired epidermal barrier function and represents a valid therapeutic target for AD.

    DOI: 10.1016/j.jid.2020.05.095

    PubMed

  • Retinal Distribution and Extracellular Activity of Granzyme B: A Serine Protease That Degrades Retinal Pigment Epithelial Tight Junctions and Extracellular Matrix Proteins Reviewed

    Joanne A. Matsubara, Yuan Tian, Jing Z. Cui, Matthew R. Zeglinski, Sho Hiroyasu, Christopher T. Turner, David J. Granville

    Frontiers in Immunology   11   2020.04( eISSN:1664-3224

     More details

    Publishing type:Research paper (scientific journal)  

    Granzymes are a family of serine proteases first shown to be intracellular initiators of immune-mediated cell death in target pathogenic cells. In addition to its intracellular role, Granzyme B (GzmB) has important extracellular functions in immune regulation and extracellular matrix (ECM) degradation. Verified substrates of extracellular GzmB activity include tight junctional and ECM proteins. Interestingly, little is known about the activity of GzmB in the outer human retina, a tissue in which the degradation of the tight junctional contacts of retinal pigment epithelial (RPE) cells and within the external limiting membrane, as well as remodeling of the ECM in Bruch's membrane, cause the breakdown of the blood-retinal barrier and slowing of metabolite transport between neuroretina and choroidal blood supply. Such pathological changes in outer retina signal early events in the development of age-related macular degeneration (AMD), a multifactorial, chronic inflammatory eye disease. This study is the first to focus on the distribution of GzmB in the outer retina of the healthy and diseased post-mortem human eye. Our results revealed that GzmB is present in RPE and choroidal mast cells. More immunoreactive cells are present in older (>65 years) compared to younger (<55 years) donor eyes, and choroidal immunoreactive cells are more numerous in eyes with choroidal neovascularization (CNV), while RPE immunoreactive cells are more numerous in eyes with soft drusen, an early AMD event. In vitro studies demonstrated that RPE-derived tight junctional and ECM proteins are cleaved by exogenous GzmB stimulation. These results suggest that the increased presence of GzmB immunoreactive cells in outer retina of older (healthy) eyes as well as in diseased eyes with CNV (from AMD) and eyes with soft drusen exacerbate ECM remodeling in the Bruch's membrane and degradation of the blood-retinal barrier. Currently there are no treatments that prevent remodeling of the Bruch's membrane and/or the loss of function of the outer blood-retinal barrier, known to promote early AMD changes, such as drusen deposition, RPE dysfunction and pro-inflammation. Specific inhibitors of GzmB, already in preclinical studies for non-ocular diseases, may provide new strategies to stop these early events associated with the development of AMD.

    DOI: 10.3389/fimmu.2020.00574

    PubMed

  • Proteases in pemphigoid diseases Reviewed

    Hiroyasu, S., Turner, C.T., Richardson, K.C., Granville, D.J.

    Frontiers in Immunology   10 ( JUN )   2019

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.3389/fimmu.2019.01454

  • Granzyme B as a therapeutic target for wound healing Reviewed

    Turner, C.T., Hiroyasu, S., Granville, D.J.

    Expert Opinion on Therapeutic Targets   23 ( 9 )   2019

     More details

    Publishing type:Research paper (scientific journal)  

    DOI: 10.1080/14728222.2019.1661380

▼display all

Books and Other Publications

  • アレルギーの臨床 2020年7月号

    廣保 翔, David J Granville, 鶴田 大輔( Role: Joint author ,  水疱性類天疱瘡における自己抗原内在化の機序)

    北隆館  2020.06 

MISC

▼display all

Presentations

  • 広範な食道びらん病変を 再燃時の主症状とした 後天性表皮水疱症の一例 Domestic conference

    谷口江利菜, 山根侑里子, 東森啓, 松本大介, 峯麻子, 大磯直毅, 鶴田大輔, 廣保翔

    第46回水疱症研究会  2025.01 

     More details

    Presentation type:Oral presentation (general)  

  • Granzyme K Contributes to PAR-2 Mediated Itch Pathway of Imiquimod-Induced Psoriasis Model(タイトル和訳中) International coauthorship International conference

    Hiroyasu Aoi, Amatya Beni, Tsuruta Daisuke, Granville David J., Hiroyasu Sho

    49th Japanese Society for Investigative Dermatology Meeting  2024.12 

     More details

    Presentation type:Oral presentation (general)  

  • Extracellular Role of Granzymes in Inflammatory Skin Diseases International conference

    Sho Hiroyasu;Daisuke Tsuruta

    第65回日本組織細胞化学会総会  2024.10 

  • 尋常性白斑における グランザイムBの機能解析 Domestic conference

    チョウ シイ, 黒田 康嵩, 楊 伶俐, 片山 一朗, 鶴田 大輔, 廣保 翔

    第4回西アジア白斑学会学術大会 第6回日本白斑学会学術大会  2024.09 

  • 治療経過中に水疱性類天疱瘡へ移行した 腫瘍随伴性天疱瘡の1例 Domestic conference

    松本大介, 谷口江利菜, 貝阿弥瞳, 奥葵, 峯麻子, 大霜智子, 古賀浩嗣, 石井文人, 鶴田大輔, 廣保翔

    第76回日本皮膚科学会西部支部学術大会  2024.09 

     More details

    Presentation type:Oral presentation (general)  

  • UJAXENGAGE-TF留学のすゝめ2024 留学体験記 Invited Domestic conference

    廣保翔

    第123回日本皮膚科学会総会  2024.06 

     More details

    Presentation type:Symposium, workshop panel (nominated)  

  • Inhibition of NETosis decreases disease severity in epidermolysis bullosa acquisita mouse model International coauthorship International conference

    Daisuke Matsumoto, Katja Bieber, Daisuke Tsuruta, Ralf Ludwig, Sho Hiroyasu

    2024 Society for Investigative Dermatology Meeting  2024.05 

     More details

    Presentation type:Oral presentation (general)  

  • Proteases in pemphigoid diseases Invited International conference

    Sho Hiroyasu

    The 13th Asian Dermatology Congress  2024.05 

     More details

    Presentation type:Oral presentation (invited, special)  

  • ナショナルデータベースを用いた 自己免疫性水疱症の疫学分析 Domestic conference

    伴奈菜加, 四宮佐恵, 河合稜太, 鍬開裕仁, 吉田寿子, 鶴田大輔, 新谷歩, 廣保翔

    第123回日本皮膚科学会総会  2024.05 

     More details

    Presentation type:Oral presentation (general)  

  • 左下眼瞼に生じた硬化性萎縮性苔癬の一例 Domestic conference

    鍬開裕仁, 廣保翔, 後藤寛之, 鶴田大輔

    第501回大阪地方会  2024.02 

     More details

    Presentation type:Oral presentation (general)  

  • 後天性表皮水疱症の病態におけるNETosisの関与 Domestic conference

    松本 大介, 廣保 翔, 鶴田 大輔

    第45回水疱症研究会  2024.01 

  • 蝶形紅斑様皮疹を呈した抗セントロメア抗体陽性型Sjoegren症候群の1例 Domestic conference

    小出 美柚, 廣保 翔, 小畠 里奈, 鶴田 大輔

    日本免疫皮膚アレルギー学会  2023.12 

  • 尋常性白斑におけるグランザイムBの機能解析 Domestic conference

    チョウシイ, 黒田 康嵩, 楊 伶俐, 片山 一朗, 鶴田 大輔, 廣保 翔

    第5回日本白斑学会  2023.09 

  • T細胞性メトトレキサート関連リンパ増殖性疾患の1例 Domestic conference

    阿部 桂奈, 平田 央, 廣保 翔, 林 恵理子, 大迫 順子, 鶴田 大輔

    大阪地方会・京滋地方会  2023.09  日本皮膚科学会-大阪地方会・京滋地方会

  • 皮膚疾患におけるグランザイムBの機能解析 International coauthorship Domestic conference

    廣保翔, チョウシイ、David, J. Granville, 鶴田大輔

    第28回日本病態プロテアーゼ学会学術集会  2023.08 

  • Bullous pemphigoid as a disease in elderly Invited International conference

    Sho Hiroyasu

    25th World Congress of Dermatology  2023.07 

  • 類天疱瘡治療の最新知見について Invited Domestic conference

    廣保 翔, 鶴田 大輔

    日本皮膚科学会西部支部大会  2023.06  日本皮膚科学会-西部支部

  • Granzyme B in Pemphigoid Diseases Invited International conference

    Sho Hiroyasu

    2023.05 

  • Extracellular role of granzyme B in vitiligo pathology International conference

    Siwei Diao, Daisuke Tsuruta, Sho Hiroyasu

    International Societies for Investigative Dermatology Meeting(ISID2023)  2023.05 

  • 落葉状天疱瘡の経過中に水疱性類天疱瘡を発症した1例 Domestic conference

    井上 美琴, 廣保 翔, 今西 久幹, 平田 央, 大畑 千佳, 鶴田 大輔

    日本臨床皮膚科医会総会  2023.05  日本臨床皮膚科医会

  • 表皮下水疱の形成機序 Invited Domestic conference

    廣保 翔

    日本皮膚科学会総会  2023.05  (公社)日本皮膚科学会

  • 自己免疫性水疱症から読み解く炎症と自己免疫のクロストーク プロテアーゼと類天疱瘡疾患 Invited Domestic conference

    廣保 翔

    日本皮膚免疫アレルギー学会総会学術大会  2022.12 

     More details

    Presentation type:Oral presentation (invited, special)  

  • ステロイド減量に難渋した、カルバマゼピン内服中の水疱性類天疱瘡の一例 Domestic conference

    福村 恵理奈, 廣保 翔, 林 恵理子, 葉山 友紀, 鶴田 大輔

    加齢皮膚医学セミナー  2022.12  加齢皮膚医学研究会

  • Protease functions in itch associated with pemphigoid diseases International coauthorship International conference

    Hiroyasu Sho, Hiroyasu Aoi, Granville David J., Tsuruta Daisuke

    Japanese Society for Investigative Dermatology Meeting  2022.10 

     More details

    Presentation type:Oral presentation (general)  

  • Recent Advancement in Autoimmunity Pathological function of proteases in pemphigoid diseases Invited International conference

    Hiroyasu Sho

    Japanese Society for Investigative Dermatology Meeting  2022.10 

     More details

    Presentation type:Oral presentation (invited, special)  

  • Upstream signaling in cytokine release from bullous pemphigoid IgG stimulated keratinocytes International conference

    Barit Jay-V James G., Hiroyasu Sho, Hiroyasu Aoi, Tsuruta Daisuke

    Japanese Society for Investigative Dermatology Meeting  2022.10 

     More details

    Presentation type:Oral presentation (general)  

  • 発作を繰り返す遺伝性血管性浮腫3型疑いの1例 Domestic conference

    寺嶋 友梨香, 廣保 翔, 綾野 悠加, 鶴田 大輔

    日本皮膚科学会西部支部大会  2022.08  日本皮膚科学会-西部支部

     More details

    Presentation type:Oral presentation (general)  

  • Brunsting-Perry型類天疱瘡様後天性表皮水疱症の1例

    後藤 芽以子, 廣保 翔, 大霜 智子, 峯 麻子, 林 大輔, 橋本 隆, 鶴田 大輔

    日本皮膚科学会雑誌  2022.01  (公社)日本皮膚科学会

  • グランザイムKはプロテアーゼ活性化受容体2を切断し痒みを誘発する(Granzyme K cleaves protease-activated receptor-2 and induces itch)

    Hiroyasu Sho, Zeglinski Matthew R., Zhao Hongyan, Hiroyasu Aoi, Tsuruta Daisuke, Granville David J.

    日本研究皮膚科学会年次学術大会・総会プログラム  2021.12  (一社)日本研究皮膚科学会

  • 表皮下水疱の形成機序 Invited

    廣保翔

    皮膚科学会総会  2021.06 

  • 類天疱瘡の新規治療

    廣保 翔, 林 大輔, 立石 千晴, 橋本 隆, 鶴田 大輔

    日本皮膚科学会雑誌  2021.05  (公社)日本皮膚科学会

  • 水疱性類天疱瘡の発生機序と治療戦略 Invited

    廣保翔

    Bullous Pemphigoid Web Seminar  2021.02 

     More details

    Presentation type:Public lecture, seminar, tutorial, course, or other speech  

  • Granzyme B Contributes to Blister Formation in Autoimmune Subepidermal Blistering Diseases Through Hemidesmosome Protein Degradation

    Hiroyasu S, Zeglinski M, Zhao H, Lennox P, Van Laeken N, Carr N, Burleigh A, Crawford R, Tateishi C, Tsuruta D, Kasprick A, Ludwig R, Granville D

    37th Annual Division of Plastic Surgery Research Day  2019.04 

     More details

    Presentation type:Oral presentation (general)  

  • Granzyme B: A Novel Target for Pemphigoid Diseases

    Hiroyasu S, Russo V, Zeglinski M, Zhao H, Machado Y, Kasprick A, Tateishi C, Nishie W, Burleigh A, Lennox P, Van, Laeken N, Carr N, Crawford R, Shimizu H, Tsuruta D, Overall C, Ludwig R, Granville D

    2019 Skin Research Group of Canada  2019 

     More details

    Presentation type:Poster presentation  

  • Granzyme B: A Novel Target for Pemphigoid Diseases

    Sho Hiroyasu, Valerio Russo, Matthew Zeglinski, Hongyan Zhao, Yoan Machado, Anika Kasprick, Chiharu Tateishi, Wataru Nishie, Angela Burleigh, Peter Lennox, Nancy Van Laeken, Nick Carr, Richard Crawford, e

    ImmunoBC Annual Meeting  2019 

     More details

    Presentation type:Oral presentation (general)  

  • Granzyme B: A Novel Target for Pemphigoid Diseases Invited

    Hiroyasu S, Russo V, Zeglinski M, Zhao H, Machado Y, Kasprick A, Tateishi C, Nishie W, Burleigh A, Lennox P, Van, Laeken N, Carr N, Crawford R, Shimizu H, Tsuruta D, Overall C, Ludwig R, Granville D

    UBC Pathology Day 2019  2019 

     More details

    Presentation type:Oral presentation (invited, special)  

  • Granzyme B Contributes to Blister Formation in Autoimmune Subepidermal Blistering Diseases Through Hemidesmosome Protein Degradation.

    2019 

     More details

    Presentation type:Oral presentation (general)  

  • GRANZYME B CONTRIBUTES TO BLISTER FORMATION IN AUTOIMMUNE SUBEPIDERMAL BLISTERING DISEASES THROUGH HEMIDESMOSOME PROTEIN DEGRADATION

    2019 Annual UBC Skin Research Day  2019 

     More details

    Presentation type:Oral presentation (general)  

▼display all

Industrial Property Rights

  • 皮膚状態の治療におけるグランザイムK活性の調節

    グランヴィル,デイビッド ジェイ., ターナー,クリストファー, ゼグリンスキー,マシュー, リチャードソン,カトリン, 廣保 翔

     More details

    property_type:Patent 

    Application no:特願2021-516564 

    Publication no:特表2022-502372 

    J-GLOBAL

Grant-in-Aid for Scientific Research

  • Does endothelin 1 induce itch and type 2 inflammatory response in pemphigoid?

    Grant-in-Aid for Scientific Research(C)  2026

  • Does endothelin 1 induce itch and type 2 inflammatory response in pemphigoid?

    Grant-in-Aid for Scientific Research(C)  2025

  • Does endothelin 1 induce itch and type 2 inflammatory response in pemphigoid?

    Grant-in-Aid for Scientific Research(C)  2024

  • 水疱性類天疱瘡発症の新たな機序;掻破とNETosis

    Grant-in-Aid for Scientific Research(C)  2024

  • 水疱性類天疱瘡発症の新たな機序;掻破とNETosis

    Grant-in-Aid for Scientific Research(C)  2023

  • 類天疱瘡の痒みにおけるプロテアーゼの機能解明

    Grant-in-Aid for Scientific Research(C)  2023

  • 水疱性類天疱瘡発症の新たな機序;掻破とNETosis

    Grant-in-Aid for Scientific Research(C)  2022

  • 類天疱瘡の痒みにおけるプロテアーゼの機能解明

    Grant-in-Aid for Scientific Research(C)  2022

  • 類天疱瘡の痒みにおけるプロテアーゼの機能解明

    Grant-in-Aid for Scientific Research(C)  2021

▼display all

Contract research

  • 加齢関連炎症性皮膚疾患に対する幹細胞標的治療法の開発

    AMED  再生・細胞医療・遺伝子治療実現加速化プログラム(再生・細胞医療・遺伝子治療研究開発課題(基礎応用研究課題))/基礎応用研究課題(個別型)  2024

Incentive donations / subsidies

  • 尋常性白斑におけるグランザイムBの機能解析

    日本白斑学会  スタートアップ研究助成  2024.04

  • 免疫老化に伴うT細胞中のグランザイムの変化は自己免疫性水疱症の発症につながるか?

    中冨健康科学振興財団  研究助成   2024.04

  • 好中球性皮膚疾患における機械刺激誘導性皮疹形成の機序解明

    一般財団法人 リディアオリリー記念ピアス皮膚科学振興財団   公募課題研究助成金   2024.04

  • 尋常性白斑におけるグランザイムBの機能解析

    日本白斑学会  スタートアップ研究助成  2023

  • 尋常性白斑におけるグランザイムBの機能解析

    大阪難病財団  2022年度第28回 医学研究助成   2022.10

  • 類天疱瘡の痒みにおけるプロテアーゼの役割解明

    日本研究皮膚科学会、(株)資生堂  JSID's Fellowship Shiseido Research Grant 2021  2022.01

  • 尋常性白斑におけるグランザイムBの機能解析

    日本白斑学会  スタートアップ研究助成  2022

  • 類天疱瘡のかゆみにおけるプロテアーゼの役割解明

    一般財団法人 リディアオリリー記念ピアス皮膚科学振興財団  公募課題研究助成金   2021

  • 水疱性類天疱瘡の痒みにおけるグランザイムの機能解明

    大阪難病財団  2021年度第27回 医学研究助成  2021

  • グランザイムB:水疱性類天疱瘡の新規治療標的

    2020.10

  • 水疱性類天疱瘡自己抗体結合によるBP180抗原の動態解析に関連するproteomics解析

    大阪難病研究財団   医学研究助成   2009

▼display all

Acceptance of Researcher

  • 2024  Number of researchers:2

  • 2023  Number of researchers:3

  • 2022  Number of researchers:2

Charge of on-campus class subject

  • 修士講義 臨床病態学2-38(皮膚・感覚器系)

    2024     Graduate school

  • 皮膚病態学

    2024     Undergraduate

  • 皮膚病態学6

    2023     Undergraduate

Number of papers published by graduate students

  • 2024

    Number of undergraduate student / college student presentations:Number of graduate students presentations:1

Number of instructed thesis, researches

  • 2024

    Number of instructed the graduation thesis:Number of graduation thesis reviews:0

    [Number of instructed the Master's Program] (previous term):[Number of instructed the Master's Program] (letter term):3

    [Number of master's thesis reviews] (chief):[Number of master's thesis reviews] (vice-chief):0

    [Number of doctoral thesis reviews] (chief):[Number of doctoral thesis reviews] (vice-chief):0

Original item・Special report (Education Activity)

  • 2024

      More details

    Original item:学生発表指導1件

  • 2024

      More details

    Original item:専攻医発表指導回数2

  • 2024

      More details

    Original item:大学院生発表指導回数2

  • 2024

      More details

    Original item:留学生論文執筆指導1件

Academic Activities

  • 論文査読20件程度

    Role(s): Peer review

    2024.04 - 2025.02

     More details

    Type:Peer review 

Foreigner acceptance

  • 2024

    foreigners accepted :2

    International Students :1

  • 2023

    foreigners accepted :3

    International Students :1

  • 2022

    foreigners accepted :1

    International Students :1